133 related articles for article (PubMed ID: 30980862)
21. Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity.
Philogene MC; Johnson T; Vaught AJ; Zakaria S; Fedarko N
Hum Immunol; 2019 Aug; 80(8):561-567. PubMed ID: 31010696
[TBL] [Abstract][Full Text] [Related]
22. Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients.
Fichtner A; Süsal C; Schröder C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Dragun D; Tönshoff B
Nephrol Dial Transplant; 2018 Jun; 33(6):1065-1072. PubMed ID: 29444269
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies.
Civieri G; Iop L; Tona F
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055116
[TBL] [Abstract][Full Text] [Related]
24. Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis.
Kang ZY; Liu C; Liu W; Li DH
Nephrol Dial Transplant; 2022 May; 37(6):1171-1180. PubMed ID: 34865146
[TBL] [Abstract][Full Text] [Related]
25. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
[TBL] [Abstract][Full Text] [Related]
26. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II type I receptor antibodies in pediatric solid organ transplant.
Pearl MH; Reed EF
Hum Immunol; 2019 Aug; 80(8):568-572. PubMed ID: 30926351
[TBL] [Abstract][Full Text] [Related]
28. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies.
Philogene MC; Bagnasco S; Kraus ES; Montgomery RA; Dragun D; Leffell MS; Zachary AA; Jackson AM
Transplantation; 2017 Mar; 101(3):608-615. PubMed ID: 27222934
[TBL] [Abstract][Full Text] [Related]
29. Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit.
Li H; Kem DC; Zhang L; Huang B; Liles C; Benbrook A; Gali H; Veitla V; Scherlag BJ; Cunningham MW; Yu X
Hypertension; 2015 Apr; 65(4):793-9. PubMed ID: 25691619
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
Pearl MH; Zhang Q; Palma Diaz MF; Grotts J; Rossetti M; Elashoff D; Gjertson DW; Weng P; Reed EF; Tsai Chambers E
Kidney Int; 2018 Jan; 93(1):260-269. PubMed ID: 28927645
[TBL] [Abstract][Full Text] [Related]
31. Pre-transplant AT
Gareau AJ; Wiebe C; Pochinco D; Gibson IW; Ho J; Rush DN; Nickerson PW
Transpl Immunol; 2018 Feb; 46():29-35. PubMed ID: 29217423
[TBL] [Abstract][Full Text] [Related]
32. Xenoreactive antibodies and latent fibrin formation in VAD and cardiac transplant recipients can confound the detection and measurement of anti-AT1R antibodies.
Oaks M; Michel K; Downey FX; Thohan V
Am J Transplant; 2018 Nov; 18(11):2763-2771. PubMed ID: 29603642
[TBL] [Abstract][Full Text] [Related]
33. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.
Fuss A; Hope CM; Deayton S; Bennett GD; Holdsworth R; Carroll RP; Coates PT
Nephrology (Carlton); 2015 Jul; 20(7):467-73. PubMed ID: 25726938
[TBL] [Abstract][Full Text] [Related]
34. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.
Reinsmoen NL; Lai CH; Heidecke H; Haas M; Cao K; Ong G; Naim M; Wang Q; Mirocha J; Kahwaji J; Vo AA; Jordan SC; Dragun D
Transplantation; 2010 Dec; 90(12):1473-7. PubMed ID: 21030904
[TBL] [Abstract][Full Text] [Related]
35. Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients.
O'Leary JG; Philippe A; Freeman R; Heidecke H; Jennings LW; Catar R; Klintmalm GB; Dragun D
Transplant Proc; 2021 Apr; 53(3):1019-1024. PubMed ID: 33579550
[TBL] [Abstract][Full Text] [Related]
36. Histopathological Relevance of Angiotensin II Type 1 Receptor in Renal Transplant Biopsy.
Sas A; Donizy P; Kościelska-Kasprzak K; Kamińska D; Mazanowska O; Krajewska M; Chudoba P; Korta K; Hałoń A; Klinger M; Banasik M
Transplant Proc; 2018; 50(6):1847-1849. PubMed ID: 30056913
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation.
Xu Q; McAlister VC; Leckie S; House AA; Skaro A; Marotta P
Am J Transplant; 2020 Jan; 20(1):282-288. PubMed ID: 31419065
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
Yu X; Li H; Murphy TA; Nuss Z; Liles J; Liles C; Aston CE; Raj SR; Fedorowski A; Kem DC
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618472
[TBL] [Abstract][Full Text] [Related]
39. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
[TBL] [Abstract][Full Text] [Related]
40. Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody.
In JW; Park H; Rho EY; Shin S; Park KU; Park MH; Song EY
Transplant Proc; 2014 Dec; 46(10):3371-4. PubMed ID: 25498054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
